
AKT-IN-6
CAS No. 1430056-54-4
AKT-IN-6( —— )
Catalog No. M34828 CAS No. 1430056-54-4
AKT-IN-6 (INCB-047775) has an inhibitory effect on ATK. Akt is an important component of cellular signaling for growth factors, cytokines, and other cell stimuli.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 46 | Get Quote |
![]() ![]() |
5MG | 65 | Get Quote |
![]() ![]() |
10MG | 107 | Get Quote |
![]() ![]() |
25MG | 210 | Get Quote |
![]() ![]() |
50MG | 342 | Get Quote |
![]() ![]() |
100MG | 536 | Get Quote |
![]() ![]() |
200MG | 762 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameAKT-IN-6
-
NoteResearch use only, not for human use.
-
Brief DescriptionAKT-IN-6 (INCB-047775) has an inhibitory effect on ATK. Akt is an important component of cellular signaling for growth factors, cytokines, and other cell stimuli.
-
DescriptionAKT-IN-6 (Example 13) is a potent Akt inhibitor. AKT-IN-6 inhibits Akt1, Akt2 and Akt3 with IC50s < 500nM, respectively. (patent WO2013056015A1).
-
In VitroAkt is a central node in cell signaling downstream of growth factors, cytokines, and other cellular stimuli. Aberrant loss or gain of Akt activation underlies the pathophysiological properties of a variety of complex diseases, including type-2 diabetes and cancer.
-
In Vivo——
-
Synonyms——
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetAkt
-
RecptorAkt
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1430056-54-4
-
Formula Weight389.43
-
Molecular FormulaC22H20FN5O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (320.98 mM; Ultrasonic )
-
SMILESCn1ncc(C#N)c1-c1ccc2C(=O)N(Cc2c1)[C@H](CN)Cc1cccc(F)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Taisheng Huang; et al.Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors. WO2013056015A1.
molnova catalog



related products
-
AKT-I-1
AKT-I-1 is a selective and reversible inhibitor of Akt1.
-
B-Raf inhibitor 1 di...
B-Raf inhibitor 1 is a potent and selective B-Raf inhibitor.
-
Xentuzumab
Xentuzumab (BI836845) is a recombinant monoclonal antibody to humanised IGF ligand that inhibits IGF1 and IGF2 growth-promoting signalling and inhibits AKT activation for the study of solid tumours.